drugset / Trial / NCT01424280

Single Dose Study of GSK1440115 in Patients With Asthma

NCT01424280 ↗

Phase 1 Completed 12 enrolled Accenture
RandomizedCrossoverSingle-blindBasic science

Summary

The purpose of this study is to assess bronchodilator effect after single dose administration of GSK1440115 in a population of mild to moderate asthmatic patients.

Timeline

Start
2011-08
Primary completion
2011-11
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject GSK1440115 Unknown 500 mg Oral
Subject GSK1440115 Unknown 750 mg Oral

Indications